Tenet Healthcare Stock
Tenet Healthcare Stock
Tenet Healthcare dominated the market today, gaining €4.00 (3.770%).
With 28 Buy predictions and not a single Sell prediction Tenet Healthcare is an absolute favorite of our community.
With a target price of 118 € there is a slightly positive potential of 6.31% for Tenet Healthcare compared to the current price of 111.0 €.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 3.770% | 21.978% | 16.230% | 73.438% | 60.870% | 125.244% | 487.488% |
| Amn Healthcare Svs | 2.780% | 6.731% | 3.738% | -26.000% | -17.164% | -15.267% | 21.804% |
| Chemed Corp. | 0.970% | -7.965% | -11.864% | 4.839% | 0.000% | 34.021% | 81.311% |
| Select Medical Holdings | 0.780% | 1.563% | -3.704% | -2.256% | 20.370% | -17.197% | 106.415% |
Comments
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $113.00 to $147.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $109.00 to $136.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $137.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat